KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biocryst Pharmaceuticals (BCRX) Total Current Liabilities: 2010-2014

Historic Total Current Liabilities for Biocryst Pharmaceuticals (BCRX) over the last 5 years, with Dec 2014 value amounting to $57.3 million.

  • Biocryst Pharmaceuticals' Total Current Liabilities rose 29.35% to $64.4 million in Q3 2015 from the same period last year, while for Sep 2015 it was $64.4 million, marking a year-over-year increase of 29.35%. This contributed to the annual value of $57.3 million for FY2014, which is 275.54% up from last year.
  • Per Biocryst Pharmaceuticals' latest filing, its Total Current Liabilities stood at $57.3 million for FY2014, which was up 275.54% from $15.3 million recorded in FY2013.
  • In the past 5 years, Biocryst Pharmaceuticals' Total Current Liabilities registered a high of $57.3 million during FY2014, and its lowest value of $15.3 million during FY2013.
  • For the 3-year period, Biocryst Pharmaceuticals' Total Current Liabilities averaged around $29.9 million, with its median value being $17.2 million (2012).
  • Per our database at Business Quant, Biocryst Pharmaceuticals' Total Current Liabilities plummeted by 34.51% in 2012 and then skyrocketed by 275.54% in 2014.
  • Over the past 5 years, Biocryst Pharmaceuticals' Total Current Liabilities (Yearly) stood at $28.0 million in 2010, then dropped by 6.07% to $26.3 million in 2011, then slumped by 34.51% to $17.2 million in 2012, then fell by 11.43% to $15.3 million in 2013, then skyrocketed by 275.54% to $57.3 million in 2014.